EUVIMEDEUVIMED entdecken
Crossref

Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS II) statement: a validated Dutch translation

Amber Werbrouck iD, Esther de Bekker-Grob, Maiwenn Al, Koen Putman, Ruben Willems

Expert Review of Pharmacoeconomics & Outcomes Research · 2024

DOI: 10.1080/14737167.2024.2324048 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Expert Review of Pharmacoeconomics & Outcomes Research, 2024. Verfasst von Amber Werbrouck und 4 weiteren Autor:innen. Beteiligte Einrichtung: Interuniversity Center for Health Economics Research, Vrije Universiteit Brussel, Brussel, Belgium. Hauptthemen laut MEDLINE: Checklist, Research Report. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: This study primarily aimed to develop a validated Dutch translation of the 28 items of the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) II. A secondary aim was to provide a worked example of a scientifically valid translation process. METHODS: A four-step process was applied: (1) forward translation, (2) backward translation, (3) quantitative validation (two back-translated English versions vs. original English version), and (4) qualitative validation (one Dutch version vs. original English version), resulting in the final Dutch CHEERS II checklist. RESULTS: During quantitative validation, the average scores indicated high language comparability (1.88 (SD 0.70); 1.70 (SD 0.73)) and interpretation similarity (1.77 (SD 0.81); 1.54 (SD 0.74)). Four items required formal revision. In the qualitative validation step, feedback primarily focused on specific terms 'outcomes,' 'benefits and harms,' '(year of) conversion,' 'any,' and 'characterizing.' CONCLUSION: Despite English being the common language of science, translating research instruments remains relevant to enhance clarity, accessibility, and inclusivity. The Dutch translation can be used by students, regulators, researchers, or others to report and evaluate reporting of economic evaluations. Our detailed description of the applied methodology can facilitate future translations of research instruments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChecklistResearch ReportHumansCost-Benefit Analysis

Stichwörter der Autor:innen

BelgiumEconomic evaluationhealth economicsreporting guidelinethe netherlandstranslationvalidation

Autor:innen und Institutionen

  • Interuniversity Center for Health Economics Research, Vrije Universiteit Brussel, Brussel, Belgium.
  • Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, The Netherlands.
  • Erasmus Centre for Health Economics Rotterdam, Erasmus University Rotterdam, Rotterdam, The Netherlands.
  • Interuniversity Center for Health Economics Research, Ghent University, Gent, Belgium.

ORCID-Profile: Amber Werbrouck

Zitieren

APA

Werbrouck, A., de Bekker-Grob, E., Al, M., Putman, K., & Willems, R. (2024). Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS II) statement: a validated Dutch translation. Expert Review of Pharmacoeconomics & Outcomes Research. https://doi.org/10.1080/14737167.2024.2324048

Vancouver

Werbrouck A, de Bekker-Grob E, Al M, Putman K, Willems R. Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS II) statement: a validated Dutch translation. Expert Review of Pharmacoeconomics & Outcomes Research. 2024. doi:10.1080/14737167.2024.2324048

BibTeX
@article{Werbrouck2024,
  author = {Werbrouck, Amber and de Bekker-Grob, Esther and Al, Maiwenn and Putman, Koen and Willems, Ruben},
  title = {Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS II) statement: a validated Dutch translation},
  journal = {Expert Review of Pharmacoeconomics & Outcomes Research},
  year = {2024},
  doi = {10.1080/14737167.2024.2324048}
}
Kostenlos starten →